Altered sensitivity of multiple brain serotonin (5HT) receptors has been hypothesized in the etiology and/or treatment of anxiety, depression, sleep disorders, sexual behaviors, and psychosis. The roles that the multiple 5HT receptor systems play in brain function are still largely unknown, as are the neuronal mechanisms through which 5HT receptors alter cellular function. To better understand the nature of the brain's 5HT receptors have been developed and will be used in conjunction with in vivo manipulations to further our understanding of the role these receptors systems play in brain function and the effects of drugs. a) Preliminary evidence for the existence of a novel brain 5HT receptor, the 5HT1D receptors, has been uncovered. Detailed radioligand binding and adenylate cyclase studies of the 5HT1D receptor will be performed in various mammalian tissues including rat and human brain. b) in order to determine the susceptibility of the 5-HT1D receptors system to sensitivity changes, 5HT transmission in rats will be altered by acute and chronic administration of serotonin neurotoxins, receptor antagonists, agonists, anxiolytics, antidepressants, and electroconvulsive shock. Alterations in the amount of 5-HT1D receptors, the interaction of the 5HT1D receptor with its associated GTP-binding protein, and the coupling between 5HT1D receptors and brain adenylate cyclase activity due to these perturbations will be monitored. c) Preliminary studies have demonstrated that 125I-DOI labels either alternatively, a unique 5HT2 receptor with high affinity for 5HT2 agonists or, alternatively, a unique 5HT2 receptor distinct from that labelled by 3H-ketanserin. In order to address this question the distribution and regulation of the 125I-DOI labelled receptors will be determined and compared with the distribution and regulation of 3H-ketanserin (an antagonist) labelled 5-HT2 receptors in multiple brain regions. d) In order to investigate the role of the brain 5HT1A receptor systems in the actions of antidepressants and novel anxiolytics the affects of these drugs on 3H-BMY 7378 (the first 5HT1A receptor antagonist radioligand), and on the associated 5HT1A receptor-mediated inhibition of adenylate cyclase activity will be monitored.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Neurosciences Research Review Committee (BPN)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albany Medical College
Schools of Medicine
United States
Zip Code
(1994) Hallucinogenic agents: drugs of abuse as neurochemical tools. NIDA Res Monogr 140:94-8
Du, Y L; Wilcox, B D; Teitler, M et al. (1994) Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells. Mol Pharmacol 45:1125-31
Rydelek-Fitzgerald, L; Wilcox, B D; Teitler, M et al. (1993) Serotonin-dependent collagenase induction in rat myometrial smooth muscle cells: mediation by the 5-HT2 receptor. Mol Cell Endocrinol 91:67-74
Rydelek-Fitzgerald, L; Wilcox, B D; Teitler, M et al. (1993) Serotonin-mediated 5-HT2 receptor gene regulation in rat myometrial smooth muscle cells. Mol Cell Endocrinol 92:253-9
Sugamori, K S; Sunahara, R K; Guan, H C et al. (1993) Serotonin receptor cDNA cloned from Lymnaea stagnalis. Proc Natl Acad Sci U S A 90:11-5
Minnear, F L; DeMichele, M A; Leonhardt, S et al. (1993) Isoproterenol antagonizes endothelial permeability induced by thrombin and thrombin receptor peptide. J Appl Physiol 75:1171-9
Fitzgerald, L W; Teitler, M (1993) Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain. Synapse 14:154-9
Leonhardt, S; Gorospe, E; Hoffman, B J et al. (1992) Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. Mol Pharmacol 42:328-35
Miller, K J; King, A; Demchyshyn, L et al. (1992) Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan. Eur J Pharmacol 227:99-102
Miller, K; Weisberg, E; Fletcher, P W et al. (1992) Membrane-bound and solubilized brain 5HT3 receptors: improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584. Synapse 11:58-66

Showing the most recent 10 out of 25 publications